Cardiometabolic Disorders News

CHICAGO — A small cohort of adults with obesity and prediabetes had lower glucose elevations and spent less time above range when they ate most of their calories before 1 p.m. compared with a more typical, later eating pattern.

CHICAGO — Older men with hypogonadism and high risk for cardiovascular disease who received testosterone therapy had similar rates of CV events as those who received placebo, according to findings from the TRAVERSE trial.

PHILADELPHIA — In this Healio video exclusive, Mikhail Kosiborod, MD, FACC, FAHA, co-chair of the Heart in Diabetes CME Conference, discusses the accomplishments of the meeting.

CHICAGO — Food insecurity, a key social determinant of health, may contribute to the relatively higher rate of metabolic syndrome among U.S. Latina women, according to findings presented at ENDO 2023.

PHILADELPHIA — A variety of pharmacologic and device-based approaches provides hope for effective and safe treatment of resistant hypertension, which can be “tedious but important” to diagnose, according to a speaker.

PHILADELPHIA — Direct oral anticoagulants for stroke prevention in patients with atrial fibrillation are safe in most high-risk populations, a speaker said during the Heart in Diabetes CME Conference.

Finerenone, a nonsteroidal mineralocorticoid receptor antagonist, may improve CV risk among patients with type 2 diabetes and kidney disease and those with albuminuria, according to a FIDELITY substudy published in JAMA Cardiology.

PHILADELPHIA — LDL is a central component of CV risk reduction and data now show clear benefits of a sustained and substantial reduction, even in the setting of very high baseline LDL, according to a speaker.

PHILADELPHIA — Postural orthostatic tachycardia syndrome is a common cardiac complication in COVID-19 survivors and research is ongoing as to optimal treatments, a speaker said during the Heart in Diabetes CME Conference.

Early menopause may be associated with increased insulin resistance, but researchers found no effects on other cardiovascular risk factors, according to a cross-sectional and longitudinal study published in Menopause.